| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
STAT3 |
| 2 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
STAT3 |
| 3 |
34714908 |
10.1182/bloodadvances.2021005486 |
2022 |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. |
STAT3 |
| 4 |
34917911 |
10.1016/j.jhepr.2021.100386 |
2022 |
ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis. |
STAT3 |
| 5 |
34922904 |
10.1016/j.cbi.2021.109779 |
2022 |
Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway. |
STAT3 |
| 6 |
34977845 |
10.1016/j.xjidi.2021.100068 |
2022 |
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders. |
STAT3 |
| 7 |
35136485 |
10.18632/oncotarget.28189 |
2022 |
GZ17-6.02 and axitinib interact to kill renal carcinoma cells. |
STAT3 |
| 8 |
35578798 |
10.1002/jcp.30777 |
2022 |
Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells. |
STAT3 |
| 9 |
35600392 |
10.3389/fonc.2022.881801 |
2022 |
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. |
STAT3 |
| 10 |
35651609 |
10.3389/fimmu.2022.878989 |
2022 |
Hyper-IgE and Carcinoma in CADINS Disease. |
STAT3 |
| 11 |
35882439 |
10.1182/bloodadvances.2022007541 |
2022 |
Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association. |
STAT3 |
| 12 |
35884913 |
10.3390/biomedicines10071608 |
2022 |
Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma. |
STAT3 |
| 13 |
36035991 |
10.3389/fcell.2022.935023 |
2022 |
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma. |
STAT3 |
| 14 |
32273478 |
10.3324/haematol.2020.251579 |
2021 |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. |
STAT3 |
| 15 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
STAT3 |
| 16 |
33247999 |
10.1111/cas.14752 |
2021 |
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. |
STAT3 |
| 17 |
33389078 |
10.1007/s00432-020-03446-w |
2021 |
Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma. |
STAT3 |
| 18 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
STAT3 |
| 19 |
33899787 |
10.1097/PAS.0000000000001691 |
2021 |
The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma. |
STAT3 |
| 20 |
33951889 |
10.3324/haematol.2020.271957 |
2021 |
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. |
STAT3 |
| 21 |
34039950 |
10.1038/s41408-021-00493-5 |
2021 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
STAT3 |
| 22 |
34272731 |
10.1111/bjh.17708 |
2021 |
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. |
STAT3 |
| 23 |
34282785 |
10.3390/cancers13133367 |
2021 |
Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma. |
STAT3 |
| 24 |
34295778 |
10.21037/tp-21-39 |
2021 |
Effect of SOCS3 on apoptosis of human trophoblasts via adjustment of the JAK2/STAT3 signaling pathway in preterm birth. |
STAT3 |
| 25 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
STAT3 |
| 26 |
34455369 |
10.1016/j.bbrc.2021.08.051 |
2021 |
Involvement of EZH2 inhibition in lenalidomide and pomalidomide-mediated growth suppression in HTLV-1-infected cells. |
STAT3 |
| 27 |
34489160 |
10.1016/j.jjcc.2021.08.018 |
2021 |
LncRNA MIAT knockdown alleviates oxygen-glucose deprivation‑induced cardiomyocyte injury by regulating JAK2/STAT3 pathway via miR-181a-5p. |
STAT3 |
| 28 |
34535012 |
10.1182/bloodadvances.2021004562 |
2021 |
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. |
STAT3 |
| 29 |
34563576 |
10.1016/j.ijbiomac.2021.09.095 |
2021 |
The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme. |
STAT3 |
| 30 |
34710755 |
10.1016/j.phymed.2021.153802 |
2021 |
Myricetin exhibit selective anti-lymphoma activity by targeting BTK and is effective via oral administration in vivo. |
STAT3 |
| 31 |
34858727 |
10.1080/2162402X.2021.2003533 |
2021 |
Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma. |
STAT3 |
| 32 |
34906296 |
NA |
2021 |
[Naringin inhibits the proliferation and invasion of Eca109 esophageal cancer cells and promotes its apoptosis by blocking JAK/STAT signal pathway]. |
STAT3 |
| 33 |
35116524 |
10.21037/tcr-20-3018 |
2021 |
Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway. |
STAT3 |
| 34 |
31383967 |
10.1038/s41379-019-0336-3 |
2020 |
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. |
STAT3 |
| 35 |
31773249 |
10.1007/s00428-019-02704-8 |
2020 |
Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas. |
STAT3 |
| 36 |
31774495 |
10.1182/blood.2019001904 |
2020 |
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. |
STAT3 |
| 37 |
31822801 |
10.1038/s41379-019-0415-5 |
2020 |
Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America. |
STAT3 |
| 38 |
31889428 |
10.1002/kjm2.12181 |
2020 |
miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer. |
STAT3 |
| 39 |
31918398 |
10.1016/j.bioorg.2019.103542 |
2020 |
JAK3 inhibitors based on thieno[3,2-d]pyrimidine scaffold: design, synthesis and bioactivity evaluation for the treatment of B-cell lymphoma. |
STAT3 |
| 40 |
32005797 |
10.1038/s41408-020-0277-6 |
2020 |
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas. |
STAT3 |
| 41 |
32010998 |
10.1002/hon.2720 |
2020 |
Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system. |
STAT3 |
| 42 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
STAT3 |
| 43 |
32641029 |
10.1186/s12906-020-03006-2 |
2020 |
Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway. |
STAT3 |
| 44 |
32735617 |
10.1371/journal.ppat.1008701 |
2020 |
Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation. |
STAT3 |
| 45 |
32779615 |
10.3960/jslrt.20019 |
2020 |
Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. |
STAT3 |
| 46 |
32922661 |
10.18632/oncotarget.27683 |
2020 |
The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL). |
STAT3 |
| 47 |
32992412 |
10.3760/cma.j.cn112151-20200205-00066 |
2020 |
[Expression of pSTAT3 and PD-L1 in extranodal NK/T cell lymphoma and its clinical significance]. |
STAT3 |
| 48 |
33323828 |
10.1097/CM9.0000000000001294 |
2020 |
R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms. |
STAT3 |
| 49 |
33376237 |
10.1038/s41392-020-00331-3 |
2020 |
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. |
STAT3 |
| 50 |
30218753 |
10.1016/j.humpath.2018.08.025 |
2019 |
Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type, is associated with disease progression and prognosis. |
STAT3 |
| 51 |
30348636 |
10.1158/1078-0432.CCR-18-1153 |
2019 |
Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma. |
STAT3 |
| 52 |
30371509 |
10.1097/PAS.0000000000001180 |
2019 |
Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas. |
STAT3 |
| 53 |
30567732 |
10.4049/jimmunol.1800876 |
2019 |
BCL6-Mediated Silencing of PD-1 Ligands in Germinal Center B Cells Maintains Follicular T Cell Population. |
STAT3 |
| 54 |
30623224 |
10.1007/s00347-018-0840-8 |
2019 |
[New molecular pathological strategies for malignant iris tumors]. |
STAT3 |
| 55 |
30770362 |
10.1182/bloodadvances.2018020602 |
2019 |
PD-L1 and tumor-associated macrophages in de novo DLBCL. |
STAT3 |
| 56 |
30935402 |
10.1186/s13045-019-0716-7 |
2019 |
Molecular pathogenic pathways in extranodal NK/T cell lymphoma. |
STAT3 |
| 57 |
30962205 |
10.1182/blood.2018880138 |
2019 |
Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells. |
STAT3 |
| 58 |
31125630 |
10.1016/j.humpath.2019.05.007 |
2019 |
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas. |
STAT3 |
| 59 |
31141539 |
10.1371/journal.pone.0216898 |
2019 |
Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL. |
STAT3 |
| 60 |
31155767 |
10.1111/jpn.13110 |
2019 |
Dietary l-arginine supplementation influences growth performance and B-cell secretion of immunoglobulin in broiler chickens. |
STAT3 |
| 61 |
31311407 |
10.1080/15384047.2019.1638670 |
2019 |
Somatic mutations in <i>KMT2D</i> and <i>TET2</i> associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders. |
STAT3 |
| 62 |
31404445 |
10.1007/s12308-019-00354-y |
2019 |
Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas. |
STAT3 |
| 63 |
31503548 |
10.1172/JCI127721 |
2019 |
Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development. |
STAT3 |
| 64 |
32063711 |
10.2147/OTT.S222189 |
2019 |
Prevalence And Clinical Significance Of Oncogenic <i>CD79B</i> And <i>MYD88</i> Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China. |
STAT3 |
| 65 |
29084771 |
10.1182/blood-2017-01-761874 |
2018 |
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. |
STAT3 |
| 66 |
29097500 |
10.3324/haematol.2017.179309 |
2018 |
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma. |
STAT3 |
| 67 |
29581848 |
10.18632/oncotarget.24512 |
2018 |
Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma. |
STAT3 |
| 68 |
29650799 |
10.1182/blood-2017-11-814913 |
2018 |
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. |
STAT3 |
| 69 |
29674644 |
10.1038/s41467-018-03987-2 |
2018 |
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. |
STAT3 |
| 70 |
29695237 |
10.1186/s12885-018-4266-0 |
2018 |
Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation. |
STAT3 |
| 71 |
29857068 |
10.1016/j.jid.2018.04.038 |
2018 |
Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. |
STAT3 |
| 72 |
29992138 |
10.1155/2018/3574534 |
2018 |
Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics. |
STAT3 |
| 73 |
30054295 |
10.1182/blood-2018-01-829424 |
2018 |
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma. |
STAT3 |
| 74 |
30093402 |
10.1182/blood-2018-03-838524 |
2018 |
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with <i>DUSP22</i> rearrangements. |
STAT3 |
| 75 |
30209121 |
10.1182/blood-2018-03-841015 |
2018 |
B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma. |
STAT3 |
| 76 |
30305518 |
10.11406/rinketsu.59.2127 |
2018 |
[Genetic analysis and its clinical implication in adult T-cell leukemia/lymphoma]. |
STAT3 |
| 77 |
30335863 |
10.1371/journal.pone.0206014 |
2018 |
Oncogenic mutations in IKKβ function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation. |
STAT3 |
| 78 |
30360879 |
10.1053/j.seminoncol.2018.07.005 |
2018 |
New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. |
STAT3 |
| 79 |
30458835 |
10.1186/s12967-018-1689-y |
2018 |
Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma. |
STAT3 |
| 80 |
30534553 |
10.1155/2018/1042597 |
2018 |
Bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma. |
STAT3 |
| 81 |
28910419 |
10.1371/journal.ppat.1006597 |
2017 |
IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. |
STAT3 |
| 82 |
29142404 |
10.4103/pm.pm_13_17 |
2017 |
Chalepin: A Compound from <i>Ruta angustifolia</i> L. Pers Exhibits Cell Cycle Arrest at S phase, Suppresses Nuclear Factor-Kappa B (NF-κB) Pathway, Signal Transducer and Activation of Transcription 3 (STAT3) Phosphorylation and Extrinsic Apoptotic Pathway in Non-small Cell Lung Cancer Carcinoma (A549). |
STAT3 |
| 83 |
27268052 |
10.1074/jbc.M116.736868 |
2016 |
Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma. |
STAT3 |
| 84 |
27564404 |
10.1111/cas.13065 |
2016 |
An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma. |
STAT3 |
| 85 |
25704763 |
10.1002/ijc.29494 |
2015 |
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting. |
STAT3 |
| 86 |
23716595 |
10.1128/MCB.01620-12 |
2013 |
STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. |
STAT3 |
| 87 |
22116549 |
10.1038/leu.2011.340 |
2012 |
Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy. |
STAT3 |
| 88 |
22735740 |
10.1039/c2mb25120e |
2012 |
Impaired JAK2-induced activation of STAT3 in failing human myocytes. |
STAT3 |
| 89 |
20802378 |
10.1097/FPC.0b013e32833deb16 |
2010 |
A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens. |
STAT3 |
| 90 |
18354204 |
10.4049/jimmunol.180.7.4805 |
2008 |
STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. |
STAT3 |
| 91 |
18636124 |
10.1371/journal.pone.0002816 |
2008 |
Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. |
STAT3 |
Datasets
Models
